Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

COPD und klangtherapie: pilotstudie zur wirksamkeit einer behandlung mit korpertambura bei COPD-patienten [German]
Hartwig B, Schmidt S, Hartwig I
Forschende Komplementaermedizin [Research in Complementary Medicine] 2016 Aug;23(4):240-244
clinical trial
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Diseases of the respiratory organs occur more often in older age, are increasing worldwide, and are common causes of morbidity and mortality. In this pilot study, it was investigated whether a single 10-min treatment with a body tambura can result in significant and effective improvement regarding the pulmonary function of patients with chronic obstructive pulmonary disease (COPD; GOLD A and B). PATIENTS AND METHODS: 54 patients were randomly assigned either to a treatment group (body tambura) or an active control group (breathing therapy). The lung function parameters forced expiratory volume in 1 s (FEV1) and inspiratory vital capacity (IVC) were measured at T1 (baseline), T2 (immediately after treatment) and at follow-up (T3, approximately 3 weeks after T1). RESULTS: The treatment group showed a significant improvement compared to the control group in both variables. The time-x-group interaction (analysis of variance) yielded p = 0.001 (FEV1) and p = 0.04 (IVC). Thereby, the treatment group also showed improvements of clinical significance. CONCLUSION: Based on these outcomes it is shown that, beside the conventional therapy according to guidelines, the sound therapy with a body tambura can be an additional but effective option with no side effects for the treatment of COPD patients to improve and stabilize their quality of life.
Published by S Karger GmbH, Freiburg.

Full text (sometimes free) may be available at these link(s):      help